Mona Tsoukleris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mona Tsoukleris has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Arlene Manns Butz
Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
10 shared publications Joan Kub
School of Nursing, Johns Hopkins University School of Medicine, Baltimore, Maryland
9 shared publicationsJennifer Walker
Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, Maryland
7 shared publicationsMary E. Bollinger
The University of Maryland School of Medicine, Department of Pediatrics
7 shared publicationsMary Elizabeth Bollinger
Department of Pediatrics, School of Medicine, University of Maryland, Baltimore, Maryland
7 shared publicationsM.E. Bollinger
6 shared publications
Latest Publications
- 1 May 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 116 (5) , 463-465
Salivary cotinine measurement for all children with persistent asthma: spit matters
- 1 May 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 116 (5) , 463-465
Salivary cotinine measurement for all children with persistent asthma: spit matters
- 1 November 2015
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 29 (6) , 536-546
Stress and Quality of Life in Urban Caregivers of Children With Poorly Controlled Asthma: A Longitudinal Analysis
- 1 November 2015
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 29 (6) , 536-546
Stress and Quality of Life in Urban Caregivers of Children With Poorly Controlled Asthma: A Longitudinal Analysis
- 1 May 2015
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 114 (5) , 385-392
Factors associated with high short-acting β2-agonist use in urban children with asthma
- 1 May 2015
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 114 (5) , 385-392
Factors associated with high short-acting β2-agonist use in urban children with asthma
- 3 April 2014
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 34 (7) , 653-661
Vancomycin‐Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors
Objective: The prevalence of vancomycin‐associated nephrotoxicity (VAN) is reported to vary from 1.0–42.6%, with most data from critically ill patients. Evaluation of VAN among internal medicine patients is lacking. Our objectives were to determine the incidence, time‐course, outcomes, and risk factors of VAN in adult internal medicine patients.Design: Retrospective cohort.Setting: Tertiary care academic medical center.Patients: A total of 125 adult internal medicine patients receiving vancomycin treatment with mean baseline creatinine clearance of 84.6 ± 27.6 ml/min.Intervention: Vancomycin treatment for a minimum of 72 hours.Measurements and Main Results: Nephrotoxicity, defined as an increase in serum creatinine of 0.5 mg/dl or 50% above baseline (whichever was larger), occurred in 17 (13.6%) of 125 patients. No patients with VAN progressed to Loss or End stage as defined by the RIFLE criteria. The incidence rate of VAN was 0.02 cases/day of vancomycin treatment. Nephrotoxicity developed at a median of 4.5 days (interquartile range [IQR] 2.2–4.9) peaked at 5.7 days (IQR: 3.8–9.6), and resolved in 70.6% of the cases within 16.5 days (IQR: 6.0–17.8) after onset. On multivariable logistic regression analysis, after controlling for hypotensive episodes, Charlson Comorbidity Index, and baseline creatinine clearance, concomitant use of piperacillin‐tazobactam was associated with increased VAN (adjusted odds ratio 5.36, 95% confidence interval 1.41–20.5).Conclusions: Vancomycin‐associated nephrotoxicity is prevalent among internal medicine patients, with 5.36‐fold higher odds if piperacillin‐tazobactam is concomitantly administered.
- 3 April 2014
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 34 (7) , 653-661
Vancomycin‐Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors
Objective: The prevalence of vancomycin‐associated nephrotoxicity (VAN) is reported to vary from 1.0–42.6%, with most data from critically ill patients. Evaluation of VAN among internal medicine patients is lacking. Our objectives were to determine the incidence, time‐course, outcomes, and risk factors of VAN in adult internal medicine patients.Design: Retrospective cohort.Setting: Tertiary care academic medical center.Patients: A total of 125 adult internal medicine patients receiving vancomycin treatment with mean baseline creatinine clearance of 84.6 ± 27.6 ml/min.Intervention: Vancomycin treatment for a minimum of 72 hours.Measurements and Main Results: Nephrotoxicity, defined as an increase in serum creatinine of 0.5 mg/dl or 50% above baseline (whichever was larger), occurred in 17 (13.6%) of 125 patients. No patients with VAN progressed to Loss or End stage as defined by the RIFLE criteria. The incidence rate of VAN was 0.02 cases/day of vancomycin treatment. Nephrotoxicity developed at a median of 4.5 days (interquartile range [IQR] 2.2–4.9) peaked at 5.7 days (IQR: 3.8–9.6), and resolved in 70.6% of the cases within 16.5 days (IQR: 6.0–17.8) after onset. On multivariable logistic regression analysis, after controlling for hypotensive episodes, Charlson Comorbidity Index, and baseline creatinine clearance, concomitant use of piperacillin‐tazobactam was associated with increased VAN (adjusted odds ratio 5.36, 95% confidence interval 1.41–20.5).Conclusions: Vancomycin‐associated nephrotoxicity is prevalent among internal medicine patients, with 5.36‐fold higher odds if piperacillin‐tazobactam is concomitantly administered.
- 27 February 2014
- Published by Taylor & Francis in Journal of Asthma
- Vol. 51 (5) , 498-507
Improving preventive care in high risk children with asthma: lessons learned
Objectives: Rates of preventive asthma care after an asthma emergency department (ED) visit are low among inner-city children. The objective of this study was to test the efficacy of a clinician and caregiver feedback intervention (INT) on improving preventive asthma care following an asthma ED visit compared to an attention control group (CON). Methods: Children with persistent asthma and recent asthma ED visits (N = 300) were enrolled and randomized into a feedback intervention or an attention control group and followed for 12 months. All children received nurse visits. Data were obtained from interviews, child salivary cotinine levels and pharmacy records. Standard t-test, chi-square and multiple logistic regression tests were used to test for differences between the groups for reporting greater than or equal to two primary care provider (PCP) preventive care visits for asthma over 12 months. Results: Children were primarily male, young (3–5 years), African American and Medicaid insured. Mean ED visits over 12 months was high (2.29 visits). No difference by group was noted for attending two or more PCP visits/12 months or having an asthma action plan (AAP). Children having an AAP at baseline were almost twice as likely to attend two or more PCP visits over 12 months while controlling for asthma control, group status, child age and number of asthma ED visits. Conclusions: A clinician and caregiver feedback intervention was unsuccessful in increasing asthma preventive care compared to an attention control group. Further research is needed to develop interventions to effectively prevent morbidity in high risk inner-city children with frequent ED utilization.
- 27 February 2014
- Published by Taylor & Francis in Journal of Asthma
- Vol. 51 (5) , 498-507
Improving preventive care in high risk children with asthma: lessons learned
Objectives: Rates of preventive asthma care after an asthma emergency department (ED) visit are low among inner-city children. The objective of this study was to test the efficacy of a clinician and caregiver feedback intervention (INT) on improving preventive asthma care following an asthma ED visit compared to an attention control group (CON). Methods: Children with persistent asthma and recent asthma ED visits (N = 300) were enrolled and randomized into a feedback intervention or an attention control group and followed for 12 months. All children received nurse visits. Data were obtained from interviews, child salivary cotinine levels and pharmacy records. Standard t-test, chi-square and multiple logistic regression tests were used to test for differences between the groups for reporting greater than or equal to two primary care provider (PCP) preventive care visits for asthma over 12 months. Results: Children were primarily male, young (3–5 years), African American and Medicaid insured. Mean ED visits over 12 months was high (2.29 visits). No difference by group was noted for attending two or more PCP visits/12 months or having an asthma action plan (AAP). Children having an AAP at baseline were almost twice as likely to attend two or more PCP visits over 12 months while controlling for asthma control, group status, child age and number of asthma ED visits. Conclusions: A clinician and caregiver feedback intervention was unsuccessful in increasing asthma preventive care compared to an attention control group. Further research is needed to develop interventions to effectively prevent morbidity in high risk inner-city children with frequent ED utilization.
- 1 September 2013
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 111 (3) , 185-189
Prescription fill patterns in underserved children with asthma receiving subspecialty care
- 1 September 2013
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 111 (3) , 185-189
Prescription fill patterns in underserved children with asthma receiving subspecialty care
- 1 March 2013
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 27 (2) , 127-134
Stress and Quality of Life in Caregivers of Inner-City Minority Children With Poorly Controlled Asthma
- 1 March 2013
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 27 (2) , 127-134
Stress and Quality of Life in Caregivers of Inner-City Minority Children With Poorly Controlled Asthma
- 1 February 2013
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 131 (2) , AB133
Association Between Medication Adherence Report Scale (MARS-5) and Asthma Outcomes in Inner City Children with Asthma
- 1 February 2013
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 131 (2) , AB133
Association Between Medication Adherence Report Scale (MARS-5) and Asthma Outcomes in Inner City Children with Asthma
- 19 September 2012
- Published by Taylor & Francis in Journal of Asthma
- Vol. 49 (9) , 977-988
Factors Associated with Completion of a Behavioral Intervention for Caregivers of Urban Children with Asthma
Background. Rates of preventive follow-up asthma care after an acute emergency department (ED) visit are low among inner-city children. We implemented a novel behavioral asthma intervention, Pediatric Asthma Alert (PAAL) intervention, to improve outpatient follow-up and preventive care for urban children with a recent ED visit for asthma. Objective. The objective of this article is to describe the PAAL intervention and examine factors associated with intervention completers and noncompleters. Methods. Children with persistent asthma and recurrent ED visits (N = 300) were enrolled in a randomized controlled trial of the PAAL intervention that included two home visits and a facilitated follow-up visit with the child’s primary care provider (PCP). Children were categorized as intervention completers, that is, completed home and PCP visits compared with noncompleters, who completed at least one home visit but did not complete the PCP visit. Using chi-square test of independence, analysis of variance, and multiple logistic regression, the intervention completion status was examined by several sociodemographic, health, and caregiver psychological variables. Results. Children were African-American (95%), Medicaid insured (91%), and young (aged 3–5 years, 56%). Overall, 71% of children randomized to the intervention successfully completed all home and PCP visits (completers). Factors significantly associated with completing the intervention included younger age (age 3–5 years: completers, 65.4%; noncompleters, 34.1%; p < .001) and having an asthma action plan in the home at baseline (completers: 40%; noncompleters: 21%; p = .02). In a logistic regression model, younger child age, having an asthma action plan, and lower caregiver daily asthma stress were significantly associated with successful completion of the intervention. Conclusions. The majority of caregivers of high-risk children with asthma were successfully engaged in this home and PCP-based intervention. Caregivers of older children with asthma and those with high stress may need additional support for program completion. Further, the lack of an asthma action plan may be a marker of preexisting barriers to preventive care.
- 19 September 2012
- Published by Taylor & Francis in Journal of Asthma
- Vol. 49 (9) , 977-988
Factors Associated with Completion of a Behavioral Intervention for Caregivers of Urban Children with Asthma
Background. Rates of preventive follow-up asthma care after an acute emergency department (ED) visit are low among inner-city children. We implemented a novel behavioral asthma intervention, Pediatric Asthma Alert (PAAL) intervention, to improve outpatient follow-up and preventive care for urban children with a recent ED visit for asthma. Objective. The objective of this article is to describe the PAAL intervention and examine factors associated with intervention completers and noncompleters. Methods. Children with persistent asthma and recurrent ED visits (N = 300) were enrolled in a randomized controlled trial of the PAAL intervention that included two home visits and a facilitated follow-up visit with the child’s primary care provider (PCP). Children were categorized as intervention completers, that is, completed home and PCP visits compared with noncompleters, who completed at least one home visit but did not complete the PCP visit. Using chi-square test of independence, analysis of variance, and multiple logistic regression, the intervention completion status was examined by several sociodemographic, health, and caregiver psychological variables. Results. Children were African-American (95%), Medicaid insured (91%), and young (aged 3–5 years, 56%). Overall, 71% of children randomized to the intervention successfully completed all home and PCP visits (completers). Factors significantly associated with completing the intervention included younger age (age 3–5 years: completers, 65.4%; noncompleters, 34.1%; p < .001) and having an asthma action plan in the home at baseline (completers: 40%; noncompleters: 21%; p = .02). In a logistic regression model, younger child age, having an asthma action plan, and lower caregiver daily asthma stress were significantly associated with successful completion of the intervention. Conclusions. The majority of caregivers of high-risk children with asthma were successfully engaged in this home and PCP-based intervention. Caregivers of older children with asthma and those with high stress may need additional support for program completion. Further, the lack of an asthma action plan may be a marker of preexisting barriers to preventive care.
- 1 May 2012
- Published by Oxford University Press (OUP)
- p. A3358
The Role Of Asthma Action Plans In Medication Adherence
- 1 May 2012
- Published by Oxford University Press (OUP)
- p. A3358
The Role Of Asthma Action Plans In Medication Adherence